-
公开(公告)号:US06620848B2
公开(公告)日:2003-09-16
申请号:US09930605
申请日:2001-08-15
申请人: Richard Mansfield Beams , Martin James Drysdale , Karl Witold Franzmann , Anthony Joseph Frend , Harold Francis Hodson , Richard Graham Knowles , Daryl David Rees , David Alan Sawyer
发明人: Richard Mansfield Beams , Martin James Drysdale , Karl Witold Franzmann , Anthony Joseph Frend , Harold Francis Hodson , Richard Graham Knowles , Daryl David Rees , David Alan Sawyer
IPC分类号: A61K31195
CPC分类号: C07C323/58
摘要: The present invention relates to novel amidino compound of formula (I): to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use as selective inhibitors of inducible nitric oxide synthase.
摘要翻译: 本发明涉及式(I)的新型脒基化合物:其制备方法,含有它们的药物组合物及其在治疗中的用途,特别是其作为诱导型一氧化氮合酶选择性抑制剂的用途。
-
公开(公告)号:US06369272B1
公开(公告)日:2002-04-09
申请号:US09341220
申请日:1999-08-24
申请人: Richard Mansfield Beams , Martin James Drysdale , Karl Witold Franzmann , Anthony Joseph Frend , Harold Francis Hodson , Richard Graham Knowles , Daryl David Rees , David Alan Sawyer
发明人: Richard Mansfield Beams , Martin James Drysdale , Karl Witold Franzmann , Anthony Joseph Frend , Harold Francis Hodson , Richard Graham Knowles , Daryl David Rees , David Alan Sawyer
IPC分类号: A61K31195
CPC分类号: C07C323/58 , C07C323/59
摘要: The present invention relates to novel amidino compound of formula (I). to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use as selective inhibitors of inducible nitric oxide synthase.
摘要翻译: 本发明涉及式(I)的新的脒基化合物,其制备方法,含有它们的药物组合物及其在治疗中的用途,特别是其作为诱导型一氧化氮合酶选择性抑制剂的用途。
-
3.
公开(公告)号:US5863931A
公开(公告)日:1999-01-26
申请号:US256032
申请日:1994-06-22
IPC分类号: C12N9/99 , A61K31/155 , A61K31/195 , A61K31/198 , A61K31/275 , A61P9/00 , A61P19/02 , A61P37/06 , A61P43/00 , C07C257/14 , C07C257/16 , C07C315/04 , C07C317/50 , C07C319/20 , C07C323/58 , C07C323/59 , A61K31/44
CPC分类号: C07C323/58 , A61K31/195 , C07C257/14 , C07C2101/02
摘要: Amidino derivatives of formula (I) and salts, and pharmaceutically acceptable esters and amides thereof, in which: R.sup.1 is a C.sub.1-6 straight or branched chain alkyl group, a C.sub.2-6 alkenyl group, a C.sub.2-6 alkynyl group, a C.sub.3-6 cycloalkyl group or a C.sub.3-6 cycloalkylC.sub.1-6 alkyl group; Q is an alkylene, alkenylene or alkynylene group having 3 to 6 carbon atoms and which may optionally be substituted by one or more C.sub.1-3 alkyl groups; a group of formula --(CH.sub.2).sub.p X(CH.sub.2).sub.q -- where p is 2 or 3, q is 1 or 2 and X is S(O).sub.x where x is 0, 1 or 2, O or NR.sup.2 where R.sup.2 is H or C.sub.1-6 alkyl; or a group of formula --(CH.sub.2).sub.r A(CH.sub.2).sub.s -- where r is 0, 1 or 2, s is 0, 1 or 2 and A is a 3 to 6 membered carbocyclic or heterocyclic ring which may optionally be substituted by one or more suitable substituents such as C.sub.1-6 alkyl, C.sub.1-6 alkoxy, hydroxy, halo, nitro, cyano, trifluoro C.sub.1-6 alkyl, amino, C.sub.1-6 alkylamino or diC.sub.1-6 alkylamino; and pharmaceutical formulations containing them are described for use in medicine novel compounds of formula (I) and the preparation of such novel compounds are also disclosed.
摘要翻译: PCT No.PCT / GB92 / 02387第 371日期:1994年6月22日 102(e)日期1994年6月22日PCT提交1992年12月23日PCT公布。 出版物WO93 / 13055 日期:1993年7月8日(一)式(I)的脒基衍生物及其盐及其药学上可接受的酯和酰胺,其中:R1是C1-6直链或支链烷基,C2-6烯基 基团,C 2-6炔基,C 3-6环烷基或C 3-6环烷基C 1-6烷基; Q是具有3至6个碳原子的亚烷基,亚烯基或亚炔基,其可以任选地被一个或多个C 1-3烷基取代; 式( - )(CH2)pX(CH2)q-,其中p是2或3,q是1或2,X是S(O)x,其中x是0,1或2,O或NR2,其中R2是H 或C 1-6烷基; 或式 - (CH 2)r A(CH 2)s - 的基团,其中r为0,1或2,s为0,1或2,A为可任选被一个或多个取代基的3至6元碳环或杂环 或更合适的取代基,例如C 1-6烷基,C 1-6烷氧基,羟基,卤素,硝基,氰基,三氟C 1-6烷基,氨基,C 1-6烷基氨基或二C 1-6烷基氨基; 和含有它们的药物制剂被描述用于医药新型式(I)化合物,并且还公开了这些新化合物的制备。
-
-